Cancer Monoclonal Antibodies Pipeline Industry Analysis - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Cancer Monoclonal Antibodies Pipeline Industry Analysis

Description:

Cancer Monoclonal Antibodies Pipeline Industry Analysis . In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. – PowerPoint PPT presentation

Number of Views:62

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cancer Monoclonal Antibodies Pipeline Industry Analysis


1
Global Cancer Monoclonal Antibodies Pipeline
Analysis
Published Date November 2013 No. of Pages
660
Price Single User US 1200 Price Corporate
User US 2400
2
New Market Research Report on Global Cancer
Monoclonal Antibodies Pipeline Analysis added to
ReportsnReports.com
Order report Global Cancer Monoclonal Antibodies
Pipeline Analysis by calling ReportsnReports.com
at 1 888 391 5441 OR send an email on
sales_at_reportsandreports.com with Global Cancer
Monoclonal Antibodies Pipeline Analysis in
subject line and your contact details.
In the past few years monoclonal antibodies
have emerged as a therapeutic modality for
cancer. These monoclonal antibodies are designed
to selectively target cancer cells and extract
various responses, thus indirectly protecting the
non cancerous cells. This characteristic of
monoclonal antibodies coupled with increasing
potential of the oncology market has made many
pharmaceutical giants to invest a significant
portion of their RD on cancer monoclonal
antibodies. In recent years the popularity of
monoclonal antibodies has increase many folds as
they have revolutionized the treatments for
cancer. The applications of Monoclonal
antibodies, which are administered intravenously,
include cancer cell marking, growth signal
blocking, the delivery of chemotherapy toxins,
and the reduction of new blood vessel growth. The
understanding of these treatments is rapidly
becoming an indispensable part of biotech
investing, and investors need to clearly
understand how monoclonal antibodies are
affecting the industry. Inquiry Before Buying
on this Report _at_ http//www.reportsnreports.com/co
ntacts/inquirybeforebuy.aspx?name270800 .
3
Global Cancer Monoclonal Antibodies Pipeline
Analysis
  • Global Cancer Monoclonal Antibodies Pipeline
    Analysis by PNS Pharma gives comprehensive
    insight on the various Monoclonal Antibodies
    being developed for the treatment of Cancer.
    Research report covers all the ongoing Monoclonal
    Antibodies being developed in various clinical
    development phases. This report enables
    pharmaceutical companies, collaborators and other
    associated stake holders to identify and analyze
    the available investment opportunity in the
    Cancer Monoclonal Antibodies market based upon
    development process. Following parameters for
    each Monoclonal Antibodies drug profile in
    development phase are covered in Global Cancer
    Monoclonal Antibodies Pipeline Analysis research
    report
  • Drug Profile Overview Alternate Names for
    Drug Active Indication Phase of Development
    Mechanism of Action Brand Name Orphan
    Designation Patent Information Country for
    Clinical Trial Owner / Originator/
    Licensee/Collaborator Administrative Route
    Drug Class ATC Codes
  • Complete report is available _at_ http//www.reportsn
    reports.com/reports/270800-global-cancer-monoclona
    l-antibodies-pipeline-analysis.html .

Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
4
Global Cancer Monoclonal Antibodies Pipeline
Analysis
Global Cancer Monoclonal Antibodies Drug Pipeline
by Clinical Phase Research 68 Preclinical
240 Phase-I 112 Phase-I/II 29 Phase-II
73 Phase-II/III 5 Phase-III 31
Preregistration 3 Marketed 27 Buy a copy of
report _at_ http//www.reportsnreports.com/Purchase.a
spx?name270800 . Table of Contents1. Global
Cancer Monoclonal Antibodies Drug Market2.
Cancer Monoclonal Antibodies Drug Clinical Phase
Research2.1 Overview2.2 Cancer Monoclonal
Antibodies Drug Profile
Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
5
Global Cancer Monoclonal Antibodies Pipeline
Analysis
3. Cancer Monoclonal Antibodies Drug Clinical
Phase Preclinical3.1 Overview3.2 Cancer
Monoclonal Antibodies Drug Profile4. Cancer
Monoclonal Antibodies Drug Clinical Phase
Phase-I4.1 Overview4.2 Cancer Monoclonal
Antibodies Drug Profile5. Cancer Monoclonal
Antibodies Drug Clinical Phase Phase-I/II5.1
Overview5.2 Cancer Monoclonal Antibodies Drug
Profile Contact sales_at_reportsandreports.com /
Call 1 888 391 5441 for further information on
Global Cancer Monoclonal Antibodies Pipeline
Analysis report OR for any other market research
and intelligence needs you may have for your
business.
Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
6
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.
About PowerShow.com